New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- Revealing the Heavy Impacts of Repeated Low-Level Head Traumas.
- New NJACTS Publication
- Applications for TIN Training Program for Multicenter Clinical Trial Management: Due MAY 30, 2025
- Frequent Exposure to Gun Violence Is Associated with Depression, Suicide and Mental Health.
- Two-Thirds of U.S. Adolescent Minors Are Impacted by State Abortion Restrictions.
Categories
- Community (2,256)
- Covid (986)
- CTO Events (6)
- News (2,875)
- Pilots (21)